Market News / Story
IBRX Stock Under Pressure: Retail Sees 'Ridiculously Cheap' Bargain As Founder Touts Sister Firm NantIQ's Aetna Work
Stocktwits ·
Stocktwits reports: Shares of ImmunityBio, Inc. (IBRX) remained under pressure this week even as founder Patrick Soon-Shiong touted a cancer-care initiative linking his separate NantIQ tech business with insurer Aetna, part of CVS Health, fueling retail hopes for indirect benefits to the biotech firm. IBRX stock rose 0.6% on Wednesday to $9.75 but remained down 5% for the week, putting it on track for its worst weekly performance since late July. Soon-Shiong Touts NantIQ’s Aetna-CVS…